Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Clinical trial NCT07130695 · RECRUITING

Trial details

NCT number: NCT07130695
Sponsor: Virginia Commonwealth University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2026-02-02
Primary completion: 2028-10-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.